Relaxing COVID-19 restrictions early could lead to vaccine resistance
The premature relaxation of COVID-19 restrictions could drive the evolution of new vaccine-resistant strains of coronavirus and put all unvaccinated individuals - particularly children - at increased risk, according to researchers at the Earlham Institute and the University of East Anglia.
An editorial published in the journal Virulence argues against the current approach towards lifting public health measures designed to curb the spread of COVID-19, warning this is playing into the hands of the virus at a time when transmission rates are so high.
The piece describes how we are in a ‘coevolutionary arms race’ with the virus and rising cases provide opportunities for it to evolve into even more transmissible variants. Of particular concern is the decision not to roll-out vaccines to the under-18s, creating a pool of vulnerable people in which the virus can continue to spread and mutate.
The researchers fear that any new variants could be more virulent, more vaccine resistant, and also more dangerous for children and clinically vulnerable groups.
Professor Neil Hall, Director of the Earlham Institute and co-author of the editorial, said: “As long as there are large numbers of unvaccinated people around the world transmitting the virus, we're all at risk. High numbers of COVID-19 cases increase the likelihood the virus will evolve to become more virulent, more transmissible, or capable of evading vaccines.
“It's critical we continue using public health measures to bring transmission rates down. We have to co-exist with caution - if we ignore global health policies which have proven to reduce infection, the virus will further adapt.
“When we weigh up the benefits and risks in vaccinating young people, we have to consider the impact on wider society too. The current approach to protecting young people seems to be letting them reach herd immunity through infection. Every day that approach continues, we give the virus the upper hand and prolong this pandemic - increasing the burden on healthcare systems and economies.”
Lead author and editor in chief of Virulence, Prof Kevin Tyler from UEA’s Norwich Medical School, said: “Over the past 17 months, economies, education and mental well-being have suffered tremendously due to the restrictions imposed in an attempt to stem the spread of the pandemic.
“Although vaccines have weakened the link between infection and mortality, they should not be used as an argument to justify a broad change in policy for countries experiencing an exponential increase in infection numbers. This is because most of the world’s population are still unvaccinated and, even in countries with efficient vaccination programmes, a significant proportion of society - particularly children - remain unprotected.
“Relaxing restrictions boosts transmission and allows the virus population to expand, which enhances its adaptive evolutionary potential and increases the risk of vaccine-resistant strains emerging by a process known as antigenic drift. Limiting the spread of Covid-19 as much as possible restricts the number of future deaths by restricting the rate with which new variants arise.
“Successive SARS-CoV-2 variants, such as the Alpha and Delta variants, have displaced one another since the outbreak. Slowing down the rate of new variant emergence requires us to act fast and decisively, reducing the number of infected people including children with vaccines and in combination with other public health policies.
“In most cases, children are not vaccinated against COVID-19 because the risk of them becoming seriously ill is very low. But new strains may evolve with higher transmissibility in children, and vaccinating children may become necessary to control the emergence of new variants.
“A policy of relaxing restrictions while children are not vaccinated risks inadvertently selecting for virulent variants that are better able to infect children and are also more problematic in vulnerable groups. Children may be particularly at risk because they are the only group that has remained unvaccinated. But there is no guarantee that the virus won't evolve the ability to infect children too, and the data shows that new variants are relatively more often found in younger age groups.
"Only when a large proportion of the world’s population is vaccinated, or has acquired immunity from infection, can we relax other social measures.
Co-lead author and evolutionary biologist Prof Cock Van Oosterhout, from UEA’s School of Environmental Sciences, said: “We have an arms race on our hands.On the human side, the arms race is fought with vaccines, new technology such as the NHS COVID-19 App, and our behavioural change, but the virus fights back by adapting and evolving.
“It is unlikely we will get ahead in this arms race unless we can significantly reduce the population size of the virus. But, given that the infection rate is about the same now as it was during the first wave, we are pretty much ‘at evens’ with this virus. And as with many other coevolutionary arms races, there are no winners.
“This is what evolutionary biologists mean when we say that coevolution is a ‘zero-sum game’. But what you cannot do is suddenly drop your guard in the middle of an arms race. That gives your opponent - the virus - a real advantage. So we must continue doing the things we have been doing for the past 18 months, particularly in countries where the number of infected people is increasing.
“Entrusting public health measures to personal responsibility is a laissez-faire approach that many governments are now taking towards COVID-19 management. During exponential transmission of virus, we need an ongoing, mandatory public health policy that includes social distancing and the compulsory wearing of facemasks in crowded indoor spaces such as shops and on public transport.
“Our current vaccination programmes alone will not end the pandemic and scientific evidence suggests that we can only safely start to relax social restrictions when the R number is below one,” he added.
The editorial, ‘COVID-19 adaptive evolution during the pandemic – Implications of new SARS-CoV-2 variants on public health policies’, appeared in the journal Virulence on July 27, 2021.
The article was led by researchers at UEA in collaboration with Norwich Research Park colleagues at the Earlham Institute, as well as the University of Pittsburgh, the University of California Davis, the University of Minnesota Twin Cities, and King Abdul Aziz University, Jeddah, Saudi Arabia.
Notes to editors.
Notes to editors
For further information, please contact:
Hayley London Media and Communications Officer, Earlham Institute
- 07760 438218
For more information or to request an interview, please contact the UEA communications office on +44 (0)1603 593496 or email email@example.com.
About Earlham Institute
The Earlham Institute (EI) is a world-leading research Institute focusing on the development of genomics and computational biology. EI is based within the Norwich Research Park and is one of eight institutes that receive strategic funding from Biotechnology and Biological Science Research Council (BBSRC) - £5.43m in 2017/18 - as well as support from other research funders. EI operates a National Capability to promote the application of genomics and bioinformatics to advance bioscience research and innovation.
EI offers a state of the art DNA sequencing facility, unique by its operation of multiple complementary technologies for data generation. The Institute is a UK hub for innovative bioinformatics through research, analysis and interpretation of multiple, complex data sets. It hosts one of the largest computing hardware facilities dedicated to life science research in Europe. It is also actively involved in developing novel platforms to provide access to computational tools and processing capacity for multiple academic and industrial users and promoting applications of computational Bioscience. Additionally, the Institute offers a training programme through courses and workshops, and an outreach programme targeting key stakeholders, and wider public audiences through dialogue and science communication activities.
About the University of East Anglia (UEA)
The University of East Anglia (UEA) is a UK Top 25 university and is ranked in the top 50 globally for research citations. Known for its world-leading research and good student experience, it was awarded Gold in the Teaching Excellence Framework and is a leading member of Norwich Research Park, one of Europe’s biggest concentrations of researchers in the fields of environment, health and plant science. www.uea.ac.uk.